Covid-19’a Histopatolojik Bir Bakış: Akciğ er, Bo brek, Beyin, Karaciğ er

2002 ve 2012 yıllarında önceki koronavavirüs salgınları olan Şiddetli akut solunum sendromu koronavirüs (SARS‐ CoV) ve Ortadoğu solunum sendromu koronavirüs (MERS ‐ CoV) ortaya çıkmıştı. Sonrasında Aralık 2019'da Çin'in Hubei eyaleti Wuhan Şehrinde SARS‐ CoV‐2 adında bir başka yüksek derecede patojenik koronavirüs ortaya çıktı ve hızla tüm dünyaya yayıldı. 11 Mart 2020 tarihinde hastalık pandemi, yani küresel salgın hastalık olarak ilan edilmiştir. Dünya Sağlık Örgütü (DSÖ) tarafından COVID-19 olarak adlandırılan bu virüs, inhalasyon veya enfekte damlacık yoluyla bulaşır ve kuluçka süresi 2 ila 14 gün arasında değişmektedir. Virüs, halsizlik, kuru öksürük, ateş, bulantı, kusma, koku kaybı, baş ağrısı ve en önemlisi solunum sıkıntısına neden olmaktadır. Birçok insan asemptomatiktir. Hastalık çoğu insanda hafif seyreder; bazılarında (genellikle yaşlılar ve kronik hastalığı olanlarda) pnömoniye, akut solunum sıkıntısı sendromuna (ARDS) ve çoklu organ fonksiyon bozukluğuna ilerleyebilir. Vaka ölüm oranının % 2 ile % 3 arasında olduğu tahmin edilmektedir. SARS-CoV-2, konakçı hücreleri anjiyotensin dönüştürücü enzim 2 (ACE2) reseptörleri yoluyla enfekte eder. Artan kanıtlar, koronavirüslerin her zaman solunum yollarıyla sınırlı olmadığını, ACE2 reseptörlerinin bulunduğu pek çok organı istila edebileceklerini göstermektedir. Dünya genelinde ilk vakanın çıktığı Aralık 2019’dan bu yana 8 aylık süre içerisinde vaka sayısı 14 milyonu, ölü sayısı 619 bini geçmiştir. Türkiye’de ise COVID-19 pozitif vaka sayısı 225 bine yaklaşmış olup maalesef aramızdan ayrılan insan sayısı 5500'ü geçmiştir. Bu derlemede COVID-19 nedeniyle hayatını kaybetmiş insanlara ait farklı organlardan alınan biyopsi örneklerinin histopatolojik bulguları bildirilmektedir.

A Histopatholoğical Overview of Covid-19: Lunğ, Kidney, Brain, Liver

In 2002 and 2012, severe acute respiratory syndrome coronavirus (SARS‐CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), which were previous outbreaks of corovavirus, appeared. Then, in December 2019, another highly pathogenic coronavirus named SARS-CoV-2 appeared in Wuhan City, Hubei province of China, and it spread rapidly all over the world. On March 11, 2020, the disease was declared as a pandemic, a global epidemic. Called COVID-19 by the World Health Organization (WHO), this virus is transmitted through inhalation or infected droplets and the incubation period ranges from 2 to 14 days. This virus causes dry cough, fever, nausea, vomiting, loss of smell, headache and most importantly respiratory distress. Many people are asymptomatic. The disease is mild in most people; in some (usually the elderly and those with chronic disease) it can progress to pneumonia, acute respiratory distress syndrome (ARDS) and multi-organ dysfunction. The case death rate is estimated to be between 2% and 3%. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells through ACE2 receptors. Increasing evidence suggests that coronaviruses are not always limited to the airways, but can invade many organs with angiotensin converting enzyme 2 (ACE2) receptors. The number of cases has exceeded 14 million and the number of deaths exceeded 619 thousand in the 8-month period since December 2019, when the first case occurred worldwide. In Turkey, the number of COVID-19 positive cases has approached 225 thousand and unfortunately the number of people who died has exceeded 5500. In this review, histopathological findings of biopsy samples taken from different organs of people who died due to COVID-19 are reported.

PDF

___

1. Su H, Yang M, Wan C, Yi L-X, Tang F, Zhu H-Y, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney international. 2020.
2. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms. ACS chemical neuroscience. 2020;11:995-8.
3. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of autoimmunity. 2020:102433.
4. Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dubé M, et al. Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses. 2020;12:14.
5. Cevik L, Alves MJ, Otero JJ. Neuropathologists play a key role in establishing the extent of COVID-19 in human patients. Free Neuropathology. 2020;1:11.
6. Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260-3.
7. Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell host & microbe. 2020.
8. Ge X-Y, Li J-L, Yang X-L, Chmura AA, Zhu G, Epstein JH, et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature. 2013;503:535-8.
9. Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, et al. Structure of the SARS-CoV-2 spike receptorbinding domain bound to the ACE2 receptor. Nature. 2020:1-6.
10. Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631-7.
11. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395:507-13.
12. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727-33.
13. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020;395:497-506.
14. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020;323:1061-9.
15. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet respir med. 2020;8:420-2.
16. Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol. 2020;33:1007-14.
17. Zhang H, Zhou P, Wei Y, Yue H, Wang Y, Hu M, et al. Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19. Ann Intern Med. 2020;172:629-32.
18. Mizuiri S, Ohashi Y. ACE and ACE2 in kidney disease. World J Nephrol. 2015;4:74-82
19. Lee SH, Lee YH, Jung SW, Kim DJ, Park SH, Song SJ, et al. Sex-related differences in the intratubular renin-angiotensin system in twokidney, one-clip hypertensive rats. Am J Physiol Renal Physiol. 2019;317:670-82.
20. Doobay MF, Talman LS, Obr TD, Tian X, Davisson RL, Lazartigues E. Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2007;292:373-81.
21. Bohmwald K, Galvez N, Ríos M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci. 2018;12:386.
22. Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci. 2020;413:116832.
23. Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J virol. 2008;82:7264-75.
24. Palasca O, Santos A, Stolte C, Gorodkin J, Jensen LJ. TISSUES 2.0: an integrative web resource on mammalian tissue expression. Database. (Oxford). 2018;2018:bay003.
25. Baig AM. Primary amoebic meningoencephalitis: neurochemotaxis and neurotropic preferences of Naegleria fowleri. ACS Publications; 2016.
26. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients. J Med Virol. 2020;92:552-5.
27. Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. Biorxiv. 2020.
28. Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID‐19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver International. 2020.